ArrePath
PrivateLast Round
VC Round
Jun 23, 2025
Total Funding Raised
$24.97M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ArrePath operates in Healthcare & Life Sciences and is based in Princeton, New Jersey. Its latest recorded funding round was a VC Round in June 2025.
ArrePath is a biotechnology company that operates a drug discovery platform intended to develop antimicrobial resistance therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Medical Imaging
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArrePath Comparables
Compare ArrePath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stoked Bio Inc. | 86% | |
| Phare Bio | 79% | |
| Terray Therapeutics | 76% |
For institutional investors. Book with your work email.
ArrePath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 23, 2025 | ||||
| Grant | Apr 2, 2025 | ||||
| Grant | Nov 19, 2024 | ||||
| Seed | Mar 3, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ArrePath Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PTX Capital | Seed |
| Nor'easter Ventures | VC Round, Seed |
| Boehringer Ingelheim | VC Round, Seed |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Grant |
| Viva BioInnovator | Seed |
| Ab Magnitude Ventures Group | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 34% MoM.
- Aug 21, 2026
Monthly visitors increased 163% MoM.
For institutional investors. Book with your work email.
ArrePath Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ArrePath's valuation, stock price, and market status.
Is ArrePath a public or private company?
ArrePath is a private company.
What is the current stock price of ArrePath?
ArrePath is a private company, so its shares have no public market price. Caplight tracks ArrePath's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ArrePath worth (valuation)?
Valuation information for ArrePath is not publicly available.
Can I buy ArrePath stock?
ArrePath shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ArrePath's last funding round?
ArrePath's most recent funding round was VC Round on June 23, 2025.
Who are the main investors in ArrePath?
Key investors in ArrePath include Boehringer Ingelheim, InnoSpark Ventures, Insight Partners.
Will ArrePath IPO soon?
No public IPO plans have been announced for ArrePath.
How can I track ArrePath secondary market activity?
Caplight tracks bids, offers, and trades in ArrePath's shares on secondary markets.